# FDA Inspection 1268221 - Sichuan Renan Pharmaceutical Co., Ltd - March 21, 2025

Source: https://www.keypedia.com/records/fda_inspections/sichuan-renan-pharmaceutical-co-ltd/c34f6243-c879-4a4e-8745-20dd1e258f4b
Source feed: FDA_Inspections

> FDA Inspection 1268221 for Sichuan Renan Pharmaceutical Co., Ltd on March 21, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1268221
- Company Name: Sichuan Renan Pharmaceutical Co., Ltd
- Inspection Date: 2025-03-21
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1268221 - 2025-03-21](https://www.keypedia.com/records/fda_inspections/sichuan-renan-pharmaceutical-co-ltd/ee2ad1c9-630f-4e2f-8548-410ba83bcf47)

Company: https://www.keypedia.com/companies/sichuan-renan-pharmaceutical-co-ltd/ac779437-fe48-4709-9fc1-5a0c7d7a0ec8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c